People with known allergies to copper or to any of the amino acids in the peptide sequence should avoid AHK-Cu
Gojkovic, S., Krezic, I., Vranes, H., Zizek, H., Drmic, D., Vuletic, L
Key Takeaways on AOD 9604 Investigational status: AOD 9604 is not an FDA-approved medication for fat loss or any other indication, which is why medical supervision is essential
Once opened, it supports bacterial growth immediately
Perfil de seguridad En los ensayos clnicos de fase II, el AOD-9604 mostr un perfil de tolerabilidad favorable, sin los eventos adversos metablicos caractersticos de la hormona de crecimiento: en particular, no se observ elevacin de la glucemia, resistencia a la insulina ni incremento de IGF-1, lo que constituye su principal diferencia de seguridad frente a la hGH completa